Your session is about to expire
← Back to Search
Accelerometer Monitoring for Neurogenic Orthostatic Hypotension
Study Summary
This trial is looking for a more objective way to assess the efficacy of treatments for neurogenic orthostatic hypotension, by using an activity monitor to track how long patients spend in the upright position during a week on placebo and a week on their regular medication.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 2 trial • 92 Patients • NCT02713126Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I can stay with my caregiver during the study.I am on multiple medications for low blood pressure when standing, but not more than pyridostigmine or fludrocortisone.I have a condition like diabetes that affects my nerves.I may have a condition like MSA, PAF, or Parkinson's with low blood pressure when standing.I have been diagnosed with a condition that causes low blood pressure when I stand.I am unable to walk or am bedridden.I experience significant dizziness or a drop in blood pressure when standing.I am currently taking blood thinners.I haven't had a heart attack, stroke, or severe chest pain in the last 6 months.I am between 40 and 80 years old.I am taking medication for low blood pressure upon standing and still have symptoms.I experience significant drops in blood pressure upon standing due to a nerve condition.
- Group 1: placebo
- Group 2: Standard treatment
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are participants able to join this clinical experiment at present?
"Affirmative. The clinicaltrial.gov website displays that this scientific examination, which was first advertised on February 5th 2021, is actively seeking volunteers. A total of 29 participants need to be enrolled from one medical facility."
Have any senior citizens been selected to participate in the trial?
"Eligibility for this medical research is restricted to patients between the age of 40 and 80. 16 trials are set aside specifically for those below 18 years old, while 158 trials were designated for seniors above 65."
What is the aggregate count of participants in this investigation?
"Affirmative. As per the information on clinicaltrials.gov, this research endeavour is still recruiting participants; it was initially posted on February 5th 2021 and recently modified on March 10th 2022. 29 patients are required from a single site location for commencement of the trial."
Does my profile meet the criteria to enter this medical trial?
"This trial is open to 29 qualified individuals who possess pure autonomic failure and are between 40-80 years of age."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger